Modeling and Targeting Advanced Prostate Cancer by Visiting Fellow Prof. YZ Wang
You are invited to attend a talk entitled: Modeling and Targeting Advanced Prostate Cancer by Visiting Fellow Prof. YZ Wang
Date: Tuesday 21 August
Time: 12pm - 1pm
Venue: TRI Room 2003
Followed by light lunch in the foyer.
PLEASE RSVP for catering purposes to [email protected] <mailto:[email protected]>
Professor Yuzhuo Wang, PhD, FCAHS
Department of Urologic Sciences, UBC
Distinguished Scientist, BC Cancer,
Senior Scientist, Vancouver Prostate Centre.
Founder and Director The Living Tumor Laboratory Fellow, the Canadian Academy of Health Sciences
Prof Wang has a dual appointment as Distinguished Scientist at the BC Cancer and Senior Scientist at the Vancouver Prostate Centre and He is also the Founder of the Living Tumor Laboratory (www.livingtumorlab.com ) and a Professor in Department of Urologic Sciences at UBC. He has authored/co-authored over 160 peer-reviewed articles and book chapters, including publications in Cancer Research, Cancer Cell, Nature, and Clinical Cancer Research. His academic contributions can be highlighted by a number of novel hypotheses he has proposed, such as hypotheses on "prostate stem cells", "epithelial-immune cell transition (EIT)", "cancer-generated lactic acid is critical, immunosuppressive metabolite rather than a 'waste product' (which has been believed for more than 90 years)" and "Tumor dormancy is a non-genetic disease". Dr. Wang is recognized for his pioneering work in the field of prostate cancer modeling. He is responsible for a novel method for establishing transplantable, patient-derived xenograft (PDX) models that closely resemble patients' malignancies. Using the methodology, his group has developed over 300 transplantable PDX models in the laboratory. Importantly such models have been effectively applied in a number of research areas, such as (i) preclinical drug efficacy studies in anti-cancer therapeutics development, (ii) discovery and validation of potential biomarkers and/or therapeutic targets, and (iii) personalized cancer therapy.??Dr. Wang has received numerous awards for his academic achievements in cancer research, such as the Innovative Scholar Award from the International Cancer Alliance for Research and Education (ICARE), US (2010), an UBC Faculty of Medicine Distinguished Achievement Award (2011), Notably, he has been inducted as a Fellow of the Canadian Academy of Health Sciences (FCAHS) in May 2018.
